Recalls, Market Withdrawals, & Safety Alerts > Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter

Recalls, Market Withdrawals, & Safety Alerts > Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter

Naloxone Recall—Two Lots from Hospira Recalled Due to Particulate Matter 

The FDA is urging Naloxone carriers to check their product against a national recall list. The maker of the drug, Hospira, has issued a voluntary recall of the opioid overdose reversal drug Naloxone due to the presence of loose particulate matter in the syringe plunger. Please inform the healthcare professionals in your network immediately. The FDA includes information on the specific product lot numbers affected by this recall.